In The Next Issue

The next issue of Cancer Control: Journal of the Moffitt Cancer Center will focus on neuro-oncology. Among the titles and authors are:

"NABTT Consortia, Its Objectives, Organization, and Contributions to Neuro-oncology to Date and Ambitious Plans for Future Progress," by Stuart A. Grossman, MD, of The Johns Hopkins Oncology Center;

"Perfusion Magnetic Resonance Imaging as an Endpoint to Assess Brain Tumor Responses to New Therapies," by Michael H. Lev, MD, and Fred Hochberg, MD, of the Massachusetts General Hospital;

"Management of Cerebral Metastases: The Role of Surgery," by Frederick F. Lang, MD, David M. Wildrick, PhD, and Raymond Sawaya, MD, of The University of Texas M.D. Anderson Cancer Center;

"Implantable Slow-Release Polymers for the Treatment of Malignant Brain Tumors," by Henry Brem, MD, of The Johns Hopkins Oncology Center;

"Current Concepts in the Management of Tumors of the Skull Base," by Akio Morita, MD, Laligam N. Sekhar, MD, and Donald C. Wright, MD, of The George Washington University Medical Center;

"Cytostatic Agents in the Management of Malignant Gliomas," by Tom Mikkelsen, MD, of Case Western Reserve University and Henry Ford Medical Center; and

"Antisense Technology: Potential Use for the Treatment of Malignant Brain Tumors," by Herbert Engelhard, MD, PhD, of Northwestern University.

The regular departments of Cancer Control will feature Cancer Economics, Clinical Research Protocols for Neuro-oncology, Imaging in Oncology, Pathology Update, Oncology Pharmacotherapy, Ten Best Readings on Neuro-oncology, and Infections in Oncology. Look for your next issue in March 1998.

Back to Cancer Control Journal Volume 5 Number 1